A phase II trial evaluating the effects of PPAR-gamma agonist (OMS405) in patients with cocaine use disorder (CUD)
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2016
At a glance
- Drugs OMS 405 (Primary)
- Indications Cocaine abuse
- Focus Therapeutic Use
- 05 Nov 2016 New trial record
- 19 Oct 2016 According to an Omeros Corporation media release, a manucripts detailing the findings has been submitted for publication to a peer-reviewed journal.
- 19 Oct 2016 Results presented at the 2016 College on Problems of Drug Dependence (CPDD) meeting, according to an Omeros Corporation media release.